. . . . . "cyclic-AMP" . . . "Dobutamine Hydrochloride" . . . "Dextrose" . . . "patients" . . . "dobutamine" . . . "congestive heart failure" . . . "cardiac decompensation" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2022-10-10T14:40:37.725434"^^ . . "Dobutamine Hydrochloride in 5% Dextrose Injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from organic heart disease or from cardiac surgical procedures. Neither dobutamine nor any other cyclic-AMP-dependent inotrope has been shown in controlled trials to be safe or effective in the long term treatment of congestive heart failure." . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "X+EPgR/Noe53EePBS928kapcDG0I537AHEIe2+1L8c/1Q0GGKTK/VmGRZ2k5BeVnF3AduziH8cjLsvUPFpE9wqjY57MgEyLL/jCGt7AhuVVNxMhgvEk/rv/v6ayzoZOon6xiHpmy3DV3DxTauANZ3vNYUn4Po6wnx/xuLHBRqW1Ch5Pa01MandcvdD8S+XEK7pBes7Oq5GQIx8hGoeZ3Tom/k6X4C6noUU+G4XA7AZ3nU2iEfa338LZcwqmaySJqlejk56c+uiOTz4FtIsGcGqPws7b1DDK9QViSmf54dxYBdV/5I/jiINEr2ye7JFAr01koml4kEqo5nu+MSdBDUQ==" . . "2022-10-10T14:40:37.725434"^^ . .